Clinical Trial Update: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intravenous immunoglobulin (Bioven) for efficacy and safety in adults with chronic primary immune thrombocytopenia has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Bioven (intravenous immunoglobulin)

Snippet

Sponsor: Biopharma Plasma LLC | Conditions: Primary Immune Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2024-09-23